Detalhe da pesquisa
1.
Immune response to ART initiation in advanced HIV infection.
HIV Med
; 24(6): 716-726, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36792544
2.
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of age.
HIV Med
; 24(1): 27-36, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35527425
3.
Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens.
Open Forum Infect Dis
; 9(3): ofac018, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35169590
4.
Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation.
J Acquir Immune Defic Syndr
; 86(4): 490-495, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33315694
5.
Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial.
Infect Dis Ther
; 10(2): 775-788, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686573
6.
Etravirine and rilpivirine: nonnucleoside reverse transcriptase inhibitors with activity against human immunodeficiency virus type 1 strains resistant to previous nonnucleoside agents.
Pharmacotherapy
; 29(3): 281-94, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19249947
7.
A Pharmacist-Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV-Positive Patients.
Pharmacotherapy
; 37(12): 1498-1506, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29023938
8.
On the horizon: promising investigational antiretroviral agents.
Curr Pharm Des
; 12(9): 1091-103, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16515488
9.
Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy.
J Acquir Immune Defic Syndr
; 69(4): 493-8, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25886923
10.
Enfuvirtide: first fusion inhibitor for treatment of HIV infection.
Am J Health Syst Pharm
; 61(12): 1242-7, 2004 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15259753
11.
Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection.
J Am Geriatr Soc
; 62(3): 447-53, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24576251
12.
Does once-daily etravirine have a role in the management of HIV-1 infection?
Drugs
; 73(3): 207-12, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23420097
13.
The next therapeutic challenge in HIV: polypharmacy.
Drugs Aging
; 30(8): 613-28, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23740523
14.
Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
Pharmacotherapy
; 31(4): 357-68, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21449625
15.
ASHP Guidelines on Pharmacist Involvement in HIV Care.
Am J Health Syst Pharm
; 73(7): 468-94, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26892679
16.
Drug Interactions Among the Antiretrovirals.
Curr Infect Dis Rep
; 6(2): 159-162, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15023279
17.
Valganciclovir: an advance in cytomegalovirus therapeutics.
Ann Pharmacother
; 36(6): 1075-9, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12022911